A B S T R A C T The effect of parathyroid hormone and calcitonin on the renal excretion of phosphate, calcium, and cyclic AMP was evaluated in the thyroparathyroidectomized hamster, a mammal apparently resistant to the phosphaturic effect of parathyroid hormone. Parathyroid hormone did not increase phosphate excretion, although it decreased excretion of calcium and increased urinary excretion of cyclic AMP. This lack of a phosphaturic response to parathyroid hormone was not reversed by administration of 25-OH vitamin D or infusions of calcium or phosphate. Calcitonin, another potentially phosphaturic hormone, also failed to increase phosphate excretion but markedly elevated urinary excretion of cyclic AMP. In hamsters pretreated with infusion of ammonium chloride, which decreased plasma and urinary pH, both parathyroid hormone and calcitonin increased excretion of phosphate as well as that of cyclic AMP. Acetazolamide had no phosphaturic effect in ammonium chloride-loaded hamsters, and it decreased cyclic AMP and calcium excretion. Alkalinization of urine by acetazolamide did not prevent the phosphaturic effect of parathyroid hormone in ammonium chloride-loaded hamsters, but it blocked the increase in urinary cyclic AMP excretion. Parathyroid hormone and calcitonin both stimulated adenylate cyclase in a cell-free system (600-g pellet) from hamster renal cortex, elevated tissue cyclic AMP levels, and activated protein kinase in tissue slices from hamster renal cortex. In acid medium, the increase in cyclic AMP 
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INTRODUCTION
Several endocrine syndromes are characterized by resistance of the kidney to the phosphaturic effect of parathyroid hormone (PTH) (1-3).1 Investigation of possible mechanisms for end organ resistance have been limited by the lack of a suitable model. Biddulph et al. (4) noticed several years ago that the administration of PTH to hamsters is not followed by the usual drop in plasma levels of phosphate. This suggested the possibility that the hamster is resistant to the phosphaturic effects of PTH. Since it is generally accepted that the phosphaturic effect of PTH is mediated through cyclic 3',5'-adenosine monophosphate (cAMP) (5), we examined the effects of PTH on renal phosphate handling and on cellular components of the PTH-sensitive cAMP system in hamsters and other closely related mammalian species. A unique dissociation between PTH-dependent cAMP formation and phosphate excretion was found in the hamster which was dependent on the acid-base status of the animal.
METHODS

Clearance studies
Male golden Syrian outbread hamsters (ARS, SpragueDawley, Inc., Madison, Wis.), 60-100 g body weight, were maintained on a diet containing 1.2% calcium, 0.8% phosphorus, and 16 ,ug/g vitamin D. Food was withheld 16 h before experiments. Hamsters had free access to water up to the time of anesthesia. Hamsters were anesthetized with inactin (130 mg/kg body weight) and thyroparathyroidectomized (TPTX) 2 h before clearance studies. A tracheostomy was performed. Catheters were inserted into the jugular vein for an infusion and in the carotid artery for withdrawal of blood and blood pressure monitoring. For collection of urine a catheter was inserted in the base of the bladder with the dome of the bladder ligated. All animals received a priming dose of 0.5 ml inulin (10%1o), and the infusion rate of inulin (1%) was kept constant at 0.02 ml/min. The clearances of inulin, phosphate, and calcium were measured in three clearance periods before and after administration of hormones and drugs. 10 (6) . Inulin in plasma and urine was measured by the anthrone method, phosphate was measured by the Fiske and Subbarow method, and calcium was measured by atomic absorption spectroscopy. Ultrafilterability of plasma phosphate and calcium was determined utilizing Amicon CF 50A membranes (Amicon Corp., Scientific Sys. Div., Lexington, Mass.). Blood pH was determined on a blood-gas analyzer (Instrumentation Laboratory, Inc., Lexington, Mass.). Urine pH was estimated at the time of collection with phenaphthazine paper and checked with the pH electrode.
For determination of urinary cAMP excretion, urine was collected in ice and then treated in boiling water bath for 3 min (6). cAMP in urine was measured by a modified protein binding assay (6) . In urine, cAMP was measured without previous purification. The urinary excretion of cAMP was calculated as picomoles of nucleotide excreted per minute relative to glomerular filtration rate (GFR) in milliliters per minute. Although this value does not measure fractional excretion of cAMP, it corrects for variations in total cAMP excretion due to variations in GFR.
Biochemical studies
For biochemical studies, animals (hamsters, gerbils, and rats) were prepared in an identical fashion to those undergoing clearance studies, including TPTX and anesthesia.
2 h after surgery, the animals were sacrificed and the kidneys were immersed in ice-cold isotonic sucrose solution and used for the following preparations.
Adenylate cyclase. Cortical and papillary parts of the kidney were dissected from the whole kidney and homogenized in buffered isotonic sucrose medium (0.25 M sucrose, 5 mM Tris, 3 mM MgCl2, and 1 mM EDTA, pH 7.4) as previously described (6, 7) . The 600 g/10-min pellet of homogenate was washed in a medium of the same composition, divided in small aliquots, frozen in dry ice, and kept frozen at -800C until assayed for adenylate cyclase activity. Adenylate cyclase activity was assayed as previously described (6, 7) . In experiments in which the 676 F. G. Knox, J. Preiss, J. J. Kim, and T. P. Dousa effects of added hormones or drugs were tested, the adenylate cyclase activity was measured in the absence and presence of the agent and differences were evaluated on a paired basis. Adenylate cyclase activity was assayed in triplicate and specific enzyme activity was expressed in picomoles of cAMP per minute per milligram of protein. cAMP phosphodiesterase activity. This was determined in 100,000-g supemate (cytosol) or in washed 100,000-g pellet membrane fraction (6) of homogenate. cAMP phosphodiesterase activity was measured by incubating the enzyme extract with 1yM [3H]5' AMP and was converted to [3H]nucleosides by incubation with 5'-nucleotidase as previously described (6) . The second incubation was stopped by heating at 95°C for 3 min and nucleoside products were separated from [3H] cAMP on QAE Sephadex columns (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) according to the procedure of Wells et al. (8) . In preliminary experiments we determined that the tested compounds did not interfere with 5'-nucleotidase activity or with the separation of nucleotides on QAE Sephadex columns. The enzyme activity was expressed in picomoles cAMP per minute per milligram of protein. All assays were run in triplicate.
Effect of hormones and drugs on tissue cAMP levels and protein kinase activation. Renal cortical tissue was cut in slices of 0.5-mm thickness with a Stadie-Riggs tissue slicer and thoroughly washed five times in a large volume of ice-cold medium (medium A) of the following composition: 140 mM NaCl, 5 mM KC1, 1.2 mM MgSO4, 0.8 mM CaCl2, 10 mM glucose, 10 mM acetic acid, 2 mM sodium phosphate, and 20 mM Tris (pH 7.4).
Measurement of protein kinase activation in intact tissue (in situ). Tissue slices were preincubated in medium A (100 mg of tissue/1.2 ml medium) for 30 min at 30°C. Slices were then transferred to fresh medium A containing 0.5 mM 1-methyl-3-isobutyl xanthine (MIX) and incubated further at 30°C for 20 min without (controls) or with tested agents added at zero incubation time. At the end of the incubation period, slices were removed from the incubation medium, minced with scissors, homogenized in a Teflon-pestle glass homogenizer in 1 ml of a medium B [containing 20 mM 2-(N-morpholine) ethanesulfonic acid, 0.25 M sucrose, 0.5 mM MIX, and 2 mM EDTA, pH 6.0] and filtered through nylon cloth. An aliquot (about 0.2 ml) of homogenate was immediately mixed with an equal volume of ice-cold 10%o TCA for determination of cAMP. The rest of the homogenate was centrifuged at 40,000g for 10 min and the supernate was immediately frozen in dry ice and later assayed without addition of exogenous cAMP (-cAMP) and another aliquot after addition of exogenous cAMP to a final concentration of 5 ,uM (+cAMP) to determine the (-cAMP/+cAMP) ratio (9) .
Based on the general molecular mechanism of protein kinase activation by cAMP, it has been shown that the ratio of protein kinase activity in fresh tissue extracts measured without added cAMP (-cAMP) to the activity measured with addition of a maximal stimulatory dose of cAMP (+cAMP), the (-cAMP/+cAMP) protein kinase activity ratio, can be used for a semiquantitative assessment of protein kinase activation in intact cells (in situ) (9) including activation by PTH and calcitonin (10) . The protein kinase activity ratio was not different whether the 40,000-g supemate was assayed immediately after homogenization or after freezing and storing the extract at -800C.
Protein kinase activity. This was assayed in an incuba- 
RESULTS
Clearance studies
The results for all 10 groups of clearance studies are summarized in Tables I and II FEc, Since ACZ markedly influenced the phosphaturic response to PTH in the hamster, the effects of PTH and ACZ, alone or in combination, were tested on renal cortical adenylate cyclase from hamsters, gerbils, 4 Significantly different from basal value at P < 0.001 (paired t test). § Significantly different from basal value at P < 0.005 (paired t test).
and rats (Table IV) . PTH increased adenylate cyclase activity approximately threefold in each species. In contrast, ACZ had no significant effect on basal adenylate cyclase activity. When PTH and ACZ were added together, there was no significant difference between the response observed after addition of PTH alone. ACZ had no effect on the activity of cAMP phosphodiesterase from hamster cortex in cytosol or in the 100,000-g pellet. The effect of PTH on in situ activation of protein kinase and changes in tissue cAMP levels were studied in renal cortical slices from rats and hamsters (Table V) . cAMP levels were significantly increased after either PTH or SCT when these were added to renal cortical slices from hamsters. Similarly, cAMP levels in renal cortical slices from rats were significantly increased after addition of PTH. The (-cAMP/+cAMP) protein kinase -activity ratio was significantly increased after PTH or SCT in hamsters and after PTH in rats. Although basal levels differed between rats and hamsters, the percent increases in protein kinase activity ratio after PTH were similar.
The effect of pH, NH4Cl, and ACZ on levels of cAMP and activation of protein kinase activity in response to PTH in tissue slices is summarized in Table VI . The basal tissue levels of cAMP and basal (-cAMP/+cAMP) protein kinase ratios were the same in the three media and were significantly increased by PTH in all three media. However, the magnitude of the increase in the tissue cAMP level and the magnitude of the protein kinase activation after PTH in the acid media plus NH4C1 were significantly less than that seen in the media with normal pH. When ACZ was added to the acid medium with NH4C1, the increase in cAMP levels and protein kinase-activation was-indistinguishable -from controls at pH 7.4 without NH4C1 and ACZ. (16) and gerbil (Knox and Dousa. Unpublished observations.) would give similar results to those seen with PTH. As illustrated in group 5, SCT also was not phosphaturic, although it markedly increased UVcAMP, stimulated adenylate cyclase, elevated tissue cAMP, and activated protein kinase in vitro. These observations suggest that the lack of a phosphaturic response to SCT is due to a defect in steps of cellular hormone action subsequent to cAMP generation and protein kinase activation as was the case for PTH.
Since hamsters have markedly alkaline urine, we explored the effects of pH on the phosphaturic effect of PTH. As illustrated in group 6, NH4Cl-induced acidosis resulted in significant decreases in FEPo4 in the TPTX hamster, and then the subsequent administration of PTH was markedly phosphaturic. This finding raised the question whether the restoration of the phosphaturic effect was due to acidification of final urine or to the decreases in blood pH. Accordingly, in group 7, hamsters were treated with NH4Cl, and subsequently the urine was alkalinized by ACZ administration. As in group 6, treatment with NH4Cl resulted in a significant decrease in FEPo4; however, the subsequent alkalinization of the final urine with ACZ had no significant effect on FEPo4.
The possibility that acidemia, rather than aciduria, was the primary mechanism for uncovering the phosphaturic effect of PTH was tested in group 8 Beck et al. reported that increased FEPo4 and UVcAMP after PTH administration was significantly blunted in acidotic rats (17) . As in the present studies, tissue cAMP accumulation was significantly lower in slices from acidotic rats. They concluded that the renal response to PTH in the rat is decreased in metabolic acidosis and that this decrease is due to inhibition of PTH-dependent cAMP systems at the level of adenylate cyclase in the renal cortex. In the hamster, the phosphaturic response was unmasked rather than inhibited in acidosis. Thus, the acidosis unmasked a phosphaturic response although cAMP accumulation and in situ protein kinase activation in response to PTH were depressed. This indicates that even in acidosis, cAMP generation and protein kinase activation are sufficient to inhibit phosphate reabsorption, provided that the PTH-sensitive phosphate transport system is made operative by lowering pH.
Unlike a previous report in the rat (18) , ACZ had no effect on adenylate cyclase and its activation by PTH. Likewise, there was no effect on cAMP phosphodiesterase. On 
